James M. Tauras
<p>My major interests are teaching cardiology to trainees of all levels, as well as researching different teaching techniques. Areas of clinical expertise are congestive heart failure and echocardiography. </p>
<p>Jim Tauras, MD, FACC, is a cardiologist, Assistant Professor, Medicine and
Course Director,Cardiovascular Diseases Physiology and Pathophysiology at
Montefiore Einstein. Dr. Tauras’ major clinical interests include critical
care cardiology, congestive heart failure and cardiac amyloidosis.
</p><p>After obtaining his Bachelor of Science in biological engineering from Cornell
University in 1995, Dr. Tauras earned his Doctor of Medicine at Weill Cornell
Medical College in 2003. He then came to Montefiore Einstein to complete an
internal medicine internship in 2004, an internal medicine residency in 2006
and a cardiology fellowship in 2009.
</p><p>Dr. Tauras has been site principal investigator for multiple national and
international clinical trials regarding novel therapeutics for acute heart
failure and cardiac amyloidosis. His work has been published in numerous
peer-reviewed journals, books, chapters, review articles and abstracts, and he
has given several invited presentations.
</p><p>Dr. Tauras is board certified by the American Board of Internal Medicine in
Cardiovascular Diseases. He is a Fellow of the American College of Cardiology.
</p>
Daniel B. Sims
<p class="MsoNormal">Daniel Sims, MD, FAHA, FACC, serves as the Program Director of the Cardiology Fellowship Training Program and is the Medical Director of the Moses Cardiac Intensive Care Unit (CICU). Dr. Sims is an Associate Professor of Medicine, Fellow of the American Heart Association (AHA), and Fellow of the American College of Cardiology (ACC). Originally from Bellmore, NY, Dr. Sims graduated from Yale University with a BA in history in 1999. He attended medical school at Emory University School of Medicine in Atlanta, GA, graduating in 2003. He stayed at Emory for his 3-year internal medicine internship and residency training, finishing in 2006. He was selected to stay an additional one year to serve as the chief resident at the Emory University Hospital. Dr. Sims did his 3-year cardiology fellowship at Columbia University Medical Center and served as chief cardiology fellow during his final year, finishing in 2010. He completed an additional one-year advanced heart failure and transplant cardiology fellowship at Columbia in 2011. Dr. Sims returned to Emory to serve on the cardiology faculty and as a member of the Center for Heart Failure Therapy and Transplantation.</p>
<p class="MsoNormal">After 2 years, Dr. Sims was recruited to Montefiore in 2013 to be the Medical Director for the Moses CICU and a member of the cardiac transplant and left ventricular assist device (LVAD) team. At Montefiore, Dr. Sims has been active in clinical research involving heart failure, cardiogenic shock, cardiac critical care, cardiac transplantation, and LVADs. He has mentored numerous residents and fellows on research projects. Dr. Sims served 2 2-year terms as a member of the AHA’s Acute Cardiac Care Committee and has been a member of the AHA writing groups for scientific statements on neuroprognostication after cardiac arrest, management of fulminant myocarditis, the prevention of complications in the CICU, and escalating and de-escalating temporary mechanical circulatory support devices. Dr. Sims is a two-time winner of the Department of Medicine’s Sharon R. Silbiger Faculty Teaching Award as the subspecialist of the year. Prior to becoming Program Director, Dr. Sims was a two-time winner of the Cardiology Fellowship Training Program “Program Director’s Training Award.” Dr. Sims is board certified in Cardiology as well as in Advanced Heart Failure and Transplant Cardiology. </p>
Dr. Sim's clinical focus has been the treatment of patients with acute and chronic heart failure due to multiple kinds of cardiomyopathy such as dilated, hypertrophic and restrictive, among others.
Dr. Sims’ research focuses on a number of topics, including the delivery of cardiac critical care and improving outcomes in the CICU and the use of temporary mechanical circulatory support with intra-aortic balloon pumps, Impella, percutaneous heart pumps, extracorporeal membrane oxygenation (ECMO) pumps and other devices to treat cardiogenic shock. He also aims to improve left ventricular assist device patient and heart transplant patient survival.
<p>Daniel Sims, MD, serves as the Program Director of the Cardiology Fellowship Training Program and is the Medical Director of the Moses Cardiac Intensive Care Unit (CICU). Dr. Sims is an Associate Professor of Medicine at our Albert Einstein College of Medicine, Fellow of the American Heart Association (AHA), and Fellow of the American College of Cardiology (ACC). Originally from Bellmore, NY, Dr. Sims graduated from Yale University with a BA in history in 1999. He attended medical school at Emory University School of Medicine in Atlanta, GA, graduating in 2003. He stayed at Emory for his 3-year internal medicine internship and residency training, finishing in 2006. He was selected to stay an additional one year to serve as the chief resident at the Emory University Hospital. Dr. Sims did his 3-year cardiology fellowship at Columbia University Medical Center and served as chief cardiology fellow during his final year, finishing in 2010. He completed an additional one-year advanced heart failure and transplant cardiology fellowship at Columbia in 2011. Dr. Sims returned to Emory to serve on the cardiology faculty and as a member of the Center for Heart Failure Therapy and Transplantation.</p><p>After 2 years, Dr. Sims was recruited to Montefiore in 2013 to be the Medical Director for the Moses CICU and a member of the cardiac transplant and left ventricular assist device (LVAD) team. His clinical focus has been the treatment of patients with acute and chronic heart failure due to multiple kinds of cardiomyopathy such as dilated, hypertrophic, and restrictive, among others. Dr. Sims also cares for patients with myocarditis, left ventricular assist devices, and cardiac transplants.</p><p>Dr. Sims has been active in clinical research involving heart failure, cardiogenic shock, temporary mechanical circulatory support devices, cardiac critical care, cardiac transplantation, and LVADs. He has mentored numerous residents and fellows on research projects and his work has been published in a number of peer-reviewed journals and textbooks. Dr. Sims served 2 2-year terms as a member of the AHA’s Acute Cardiac Care Committee and has been a member of the AHA writing groups for scientific statements on neuroprognostication after cardiac arrest, management of fulminant myocarditis, the prevention of complications in the CICU, and escalating and de-escalating temporary mechanical circulatory support devices. Dr. Sims is a two-time winner of the Department of Medicine’s Sharon R. Silbiger Faculty Teaching Award as the subspecialist of the year. Prior to becoming Program Director, Dr. Sims was a two-time winner of the Cardiology Fellowship Training Program “Program Director’s Training Award.” Dr. Sims is a member of the AHA, the ACC, and the International Society of Heart and Lung Transplantation. Additionally, he is board certified in Cardiology as well as Advanced Heart Failure and Transplant Cardiology.</p>
Jooyoung (Julia) Shin
<p align="left" style=" word-break: normal; text-align: left;"><span style=" color: black; font-size: 12.0pt; font-family: 'Times New Roman';">Clinical cardiology, specifically end-stage congestive heart failure, mechanical circulatory support, and cardiac transplantation.  </span></p>
Dr. Shin's clinical focus is on caring for patients with heart failure, particularly providing expertise in advanced heart failure, heart transplantation, and mechanical circulatory support.
Heart failure treatment is the primary focus of Dr. Shin’s research. She is the site principal investigator for the effectiveness of omecamtiv mecarbil/AMG 423 to treat chronic heart failure with reduced ejection fraction (GALACTIC-HF) and multiple cardiac sensors for the management of heart failure (MANAGE-HF) trials.
<p>Jooyoung Julia Shin, MD, is Fellowship Director, Advanced Heart Failure and Transplant Cardiology Fellowship Program and Associate Professor, Medicine at Montefiore Einstein. Dr. Shin’s clinical focus centers on heart failure, cardiac transplantation and mechanical circulatory support.</p><p>After obtaining her Bachelor of Science from the University of Michigan in 1994, Dr. Shin earned her Doctor of Medicine at George Washington University in 1999. She completed an internship and residency in internal medicine at the University of Maryland in 2002 before completing a cardiovascular disease fellowship at Emory University in 2005. Following this, Dr. Shin remained at Emory to complete an additional fellowship in advanced heart failure and transplant cardiology in 2006.</p><p>Dr. Shin’s research focuses on fellow education. She has been principal investigator and co-principal investigator on several funded research projects, and she has presented at invited lectures nationwide. Her work has also been published in numerous peer-reviewed journals, and she has been a reviewer for scientific publications, including the <em>Mayo Clinic Proceedings</em>, the <em>American Journal of Cardiology</em> and <em>Pacing and Clinical Electrophysiology</em>, among others.</p><p>Dr. Shin is board certified by the American Board of Internal Medicine in Cardiovascular Disease, Internal Medicine and Advanced Heart Failure and Transplant Cardiology. She is a member of the American College of Cardiology and the International Society for Heart and Lung Transplantation.</p>
Snehal R. Patel
<p>Clinical areas of expertise include heart failure, cardiac transplantation, mechanical circulatory support.</p>
Shrivatsa Nadiger
Ulrich P. Jorde
<p>Dr. Ulrich Jorde’s laboratory is focused on translational research in advanced heart failure including heart replacement therapy; i.e. durable mechanical circulatory support (left ventricular assist devices/ “artificial hearts”) or cardiac transplantation.</p>
<p>The basis for Dr. Jorde's work is a large clinical program with approximately 2000 heart failure admissions, 35 adult cardiac transplants, and 50 left ventricular assist devices annually. All work is done in close collaboration with cardiothoracic surgical colleagues.</p>
<p>Representative examples of Dr. Jorde’s research include:</p>
<ol>
<li>Investigator initiated mechanistic studies:
<ul type="disc">
<li>Studies of the nasal mucosa vasculature in “pulseless” heart failure patients on continuous-flow LVADs</li>
<li>Hemolysis patterns in CF-LVAD patients and their association with device thrombosis (collaboration with Henny Billett, MD – Hematology)</li>
<li>Reversal of heart failure induced diabetes in CF-LVAD patients</li>
</ul>
</li>
<li>Basic Science Collaborations – Myocardial recovery during mechanical circulatory support (collaboration with Nicholas Frangogiannis, MD)</li>
<li>Outcomes/epidemiology studies – Effect of center volume on survival during heart failure hospital admission</li>
<li>Multicenter studies of investigational mechanical circulatory support devices:
<ul type="disc">
<li>MOMENTUM Trial: A 1200-patient study of long term durable support as bridge to transplantation or destination therapy with the HM III (national PI: Daniel Goldstein, MD)</li>
<li>SHIELD 2: A 452 patient study of acute mechanical circulatory support with the Percutaneous Heart Pump. (national PI: Ulrich Jorde, MD)</li>
</ul>
</li>
</ol>
Specialization in heart failure, cardiac transplantation and mechanical circulatory support for left ventricular assist devices (LVAD); and cardiogenic shock
<ol>
<li>Uriel N, Naka Y, Colombo PC, Farr M, Pak SW, Cotarlan V, Albu JB, Gallagher D, Mancini D, Ginsberg HN, Jorde UP. Improved diabetic control in advanced heart failure patients treated with left ventricular assist devices. Eur J Heart Fail. 2011 Feb;13(2):195-9. </li>
<li>Hirsh B, Mignatti A, Sims DB, Uriel N, Colombo PC, Jorde UP. Effect of beta Blocker Cessation on Chronotropic Incompetence and Exercise Tolerance in Patients with Advanced Heart Failure. Circ Heart Fail. 2012 Sep 1;5(5):560-5.</li>
<li>Uriel N, Morrison K, Garan AR, Kato T, Yuzefpolskaya M, latif F, Restaino S, Mancini DM, Flannery M, Takayama H, John R, Colombo PC, Naka Y, Jorde UP. Development of a novel echocardiography ramp test for speed optimization and diagnosis of device thrombosis in continuous flow left ventricular assist devices: The Columbia Ramp Study. J Am Coll Cardiol. 2012 Oct 30;60(18):1764-75.</li>
<li>Uriel N, Gonzalez-Costello J, Mignatti A, Morrison K, Colombo PC, Jorde UP. Adrenergic Activation Governs Fuel Substrate Availability and Insulin Resistance in Patients with Congestive Heart Failure. J JACC: Heart Failure Vol. 1, Issue 4, Pages 331-337. </li>
<li>Jorde UP , Khushwaha SS, Tatooles AJ, Naka Y, Bhat G, Long JW, Horstmanshof D, Kormos RL, Teuteberg JJ, Slaughter MS, Birks EJ, Farrar DJ, Park SJ. Two-Year Outcomes in the Destination Therapy Post-FDA-Approval Study with a Continuous Flow Left Ventricular Assist Device: A Prospective Study Using the INTERMACS Registry. J Am Coll Cardiol. 2014 May 6;63(17):1751-7. </li>
<li>Jorde UP, Uriel N, Nahumi N, Bejar D, Gonzalez-Costello J, Thomas SS, Han J, Morrison KA, Jones S, Kodali S, Hahn RT, Shames S, Colombo PC, Takayama H, Naka Y. Prevalence, significance, and management of aortic insufficiency in continuous flow left ventricular assist device recipients. Circ HF; Circ Heart Fail. 2014 Mar 1;7(2):310-9.</li>
</ol>
Edwin C.W. Ho
Dr. Hos' clinical focus is on valvular heart disease, especially novel transcatheter valve repair and replacement technologies.
Following his clinical interests, Dr. Ho’s research focuses on valvular heart disease and advanced cardiac imaging. His research has been published in reviewed journals, and he has been invited to present and participate as faculty at several international cardiology and valve meetings.
<p>Edwin Ho, MD, is Co-Director of the Heart Valve/Structural Heart Center at Montefiore. His clinical focus is on valvular heart disease, especially novel transcatheter valve repair and replacement technologies.</p><p>In 2010, Dr. Ho received his Doctor of Medicine from the University of Toronto in Toronto, Ontario. He continued at the institution for his postdoctoral training with a three-year residency in general internal medicine from 2010 to 2013, followed by a three-year residency in adult cardiology, which he completed in 2016. He then pursued a clinical fellowship in echocardiography, interventional echocardiography and valvular heart disease at St. Michael’s Hospital in Toronto. After completing this in 2017, he continued his postdoctoral training at the University Hospital of Zurich in Switzerland, completing a clinical fellowship in interventional echocardiography and valvular heart disease in 2017 to 2019.</p><p>Following his clinical interests, Dr. Ho’s research focuses on valvular heart disease and advanced cardiac imaging. His research has been published in reviewed journals, and he has been invited to present and participate as faculty at several international cardiology and valve meetings. He has been an invited manuscript reviewer for <em>Circulation: Cardiovascular Imaging</em> and <em>Cardiovascular Medicine</em>.</p>